Indication
Nosocomial pneumonia due to Haemophilus influenzae
Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission. Read more about Nosocomial pneumonia due to Haemophilus influenzae
65 drugs 52 manufacturers
Drugs that treat it
Common Nosocomial pneumonia due to Haemophilus influenzae therapies.
LEVOFLOXACIN
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission.
It primarily affects hospitalized patients, particularly those undergoing mechanical ventilation, older adults, individuals with structural lung disease, or those with impaired airway clearance and consciousness.
Pathophysiologically, the condition arises when endogenous or aspirated organisms from the upper respiratory tract colonize the lower airways, triggering alveolar inflammation, exudate accumulation, and impaired gas exchange.
Clinically, it is defined by new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and local signs of infection, such as fever, purulent sputum production, leukocytosis, and worsening respiratory failure.
- uspharmacist.com
Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission It primarily affects hospitalized patients, particularly those undergoing mechanical ventilation, older adults, individuals with structural lung disease, or those with impaired airway clearance and consciousness
- shmabstracts.org
Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission It primarily affects hospitalized patients, particularly those undergoing mechanical ventilation, older adults, individuals with structural lung disease, or those with impaired airway clearance and consciousness Clinically, it is defined by new or progressive pulmonar...
- nih.gov
Nosocomial pneumonia due to *Haemophilus influenzae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative coccobacillus *Haemophilus influenzae*, developing 48 hours or more after inpatient admission It primarily affects hospitalized patients, particularly those undergoing mechanical ventilation, older adults, individuals with structural lung disease, or those with impaired airway clearance and consciousness Clinically, it is defined by new or progressive pulmonar...
- cdc.gov
Pathophysiologically, the condition arises when endogenous or aspirated organisms from the upper respiratory tract colonize the lower airways, triggering alveolar inflammation, exudate accumulation, and impaired gas exchange
- nih.gov
Pathophysiologically, the condition arises when endogenous or aspirated organisms from the upper respiratory tract colonize the lower airways, triggering alveolar inflammation, exudate accumulation, and impaired gas exchange Clinically, it is defined by new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and local signs of infection, such as fever, purulent sputum production, leukocytosis, and worsening respiratory failure
- clevelandclinic.org
Pathophysiologically, the condition arises when endogenous or aspirated organisms from the upper respiratory tract colonize the lower airways, triggering alveolar inflammation, exudate accumulation, and impaired gas exchange
Personalize your experience
Follow Nosocomial pneumonia due to Haemophilus influenzae and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.